On April 8 at 9 PM Eastern time, the Mesothelioma Applied Research Foundation will hold a new installment of its Meet the Experts series, featuring Dr. Joanna C. Horobin, the Chief Medical Officer at Verastem, Inc., who will discuss the companys latest drug, defactinib, which is being developed for use in patients with pleural mesothelioma.
Source: www.topix.com Via newsmixx: home News